Minicircle DNA vectors devoid of bacterial DNA result in persistent and high-level transgene expression in vivo
- PMID: 12946323
- DOI: 10.1016/s1525-0016(03)00168-0
Minicircle DNA vectors devoid of bacterial DNA result in persistent and high-level transgene expression in vivo
Abstract
The loss of transgene expression has been a major obstacle to the development of nonviral vectors for the treatment of human diseases. We previously demonstrated that bacterial DNA linked to a mammalian expression cassette resulted in transcriptional silencing of the transgene in vivo. To confirm these studies and develop a means to produce a robust DNA vector that is not silenced in vivo, we developed a phage phiC31 integrase-mediated intramolecular recombination technology to prepare minicircle vector DNA devoid of the bacterial backbone and then compared the transgene expression profile of the minicircle with different molecular forms of plasmid DNAs in mice. We demonstrate that minicircular DNAs devoid of bacterial sequences expressed 45- and 560-fold more serum human factor IX and alpha1-antitrypsin, respectively, compared to standard plasmid DNAs transfected into mouse liver. Our data suggest that minicircles are capable of expressing high and persistent levels of therapeutic products in vivo and have a great potential to serve as episomal vectors for the treatment of a wide variety of diseases.
Similar articles
-
Increased maintenance and persistence of transgenes by excision of expression cassettes from plasmid sequences in vivo.Hum Gene Ther. 2005 May;16(5):558-70. doi: 10.1089/hum.2005.16.558. Hum Gene Ther. 2005. PMID: 15916481
-
Improved production and purification of minicircle DNA vector free of plasmid bacterial sequences and capable of persistent transgene expression in vivo.Hum Gene Ther. 2005 Jan;16(1):126-31. doi: 10.1089/hum.2005.16.126. Hum Gene Ther. 2005. PMID: 15703495
-
Silencing of episomal transgene expression by plasmid bacterial DNA elements in vivo.Gene Ther. 2004 May;11(10):856-64. doi: 10.1038/sj.gt.3302231. Gene Ther. 2004. PMID: 15029228
-
A novel gene expression system: non-viral gene transfer for hemophilia as model systems.Adv Genet. 2005;54:143-77. doi: 10.1016/S0065-2660(05)54007-0. Adv Genet. 2005. PMID: 16096011 Review.
-
Towards effective non-viral gene delivery vector.Biotechnol Genet Eng Rev. 2015 Apr-Oct;31(1-2):82-107. doi: 10.1080/02648725.2016.1178011. Biotechnol Genet Eng Rev. 2015. PMID: 27160661 Review.
Cited by
-
Molecular targets and strategies in the development of nucleic acid cancer vaccines: from shared to personalized antigens.J Biomed Sci. 2024 Oct 9;31(1):94. doi: 10.1186/s12929-024-01082-x. J Biomed Sci. 2024. PMID: 39379923 Free PMC article. Review.
-
A comprehensive comparison of DNA and RNA vaccines.Adv Drug Deliv Rev. 2024 Jul;210:115340. doi: 10.1016/j.addr.2024.115340. Epub 2024 May 27. Adv Drug Deliv Rev. 2024. PMID: 38810703 Review.
-
Transcription Factor Binding Site in Promoter Determines the Pattern of Plasmid-Based Transgene Expression In Vivo.Pharmaceutics. 2024 Apr 15;16(4):544. doi: 10.3390/pharmaceutics16040544. Pharmaceutics. 2024. PMID: 38675205 Free PMC article.
-
Antibiotic-Free Gene Vectors: A 25-Year Journey to Clinical Trials.Genes (Basel). 2024 Feb 20;15(3):261. doi: 10.3390/genes15030261. Genes (Basel). 2024. PMID: 38540320 Free PMC article. Review.
-
The intracellular visualization of exogenous DNA in fluorescence microscopy.Drug Deliv Transl Res. 2024 Aug;14(8):2242-2261. doi: 10.1007/s13346-024-01563-4. Epub 2024 Mar 25. Drug Deliv Transl Res. 2024. PMID: 38526634 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources